Skip to content

Effects of Feeding Schedule on the Development of ICU Delirium

Effects of Feeding Schedule on the Development of ICU Delirium

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04870554
Enrollment
3
Registered
2021-05-03
Start date
2021-04-26
Completion date
2024-06-03
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Delirium

Keywords

Mechanical ventilation, Tube feeds

Brief summary

This study will investigate if enteric feeding schedules alter the development of delirium in Intensive Care Unit patients who have been placed on mechanical ventilation. Delirium is an altered state of consciousness, which can involve agitation, inattention, and decreased awareness. We will enroll Intensive Care Unit patients who have been placed on a ventilator and are being given tube feedings. We will randomize participants into two groups: one group will receive continuous feedings via feeding tube, and the other group will receive feedings on a schedule to mimic breakfast, lunch, a snack, and dinner. Subjects will be assessed for the development of delirium. Subjects will also be monitored for sleep quality.

Detailed description

Patients will need to have at least 48 hours of enteric feedings to be included, and will be stratified by their APACHE IV score. Patients will be randomized into time restricted feeding vs continuous feeding by investigators, with no change in caloric intake nor nutrient content from orders. Patients will be assessed for delirium using the CAM-ICU (Confusion Assessment Method in the Intensive Care Unit) screening tool every twelve hours. At the time of the CAM ICU assessment, as part of the experimental design, the patient's sleep will be monitored by X8 Sleep Profiler device, placed and secured to their forehead, and the Sleep Profiler device will collect information regarding sleep quality as assessed by relative delta power, relative theta power and relative beta power.

Interventions

BEHAVIORALEnteric feeding

All subjects will be given nutrition enterally, corresponding to their calculated nutritional needs.

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Participants will be under sedation. The outcome assessor for delirium (primary outcome) is not blinded. Assessors rating the sleep quality (secondary outcome) will be blinded.

Intervention model description

Patients will be randomly assigned to one of two treatment groups: standard continuous feeding or timed feeding.

Eligibility

Sex/Gender
ALL
Age
21 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Admitted to the ICU * Mechanically ventilated * Receiving enteric feedings for at least 48 hours

Exclusion criteria

* Pregnancy * Previously diagnosed neurocognitive disorders, * Alcohol withdrawal and history of alcohol dependence

Design outcomes

Primary

MeasureTime frameDescription
Percent of patients developing delirium.48 hours after admission to the ICU.The development of delirium as measured by the CAM-ICU (Confusion Assessment Method for the ICU) protocol. The percent of patients developing delirium will be assessed in each arm. Delirium will be assessed every 12 hours.

Secondary

MeasureTime frameDescription
Change in sleep quality assessed using delta power.Measurement will be made from study enrollment to extubation, up to 1 week.Change in relative delta power on EEG will be assessed in each arm.
Change in sleep quality assessed using theta power.Measurement will be made from study enrollment to extubation, up to 1 week.Change in relative theta power on EEG will be assessed in each arm.
Change in sleep quality using beta power.Measurement will be made from study enrollment to extubation, up to 1 week.Change in relative beta power on EEG will be assessed in each arm.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026